Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anti-angiogenic therapies in the treatment of Waldenstrom's Macroglobulinemia.

Anti-angiogenic therapies in the treatment of Waldenstrom's Macroglobulinemia. Curr Cancer Drug Targets. 2011 Nov; 11(9):1025-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.